Postmenopausal Osteoporosis: Latest Guidelines.
AACE
ACE
DXA
FRAX
Fragility fracture
Osteopenia
Postmenopausal osteoporosis
Treatment guidelines
Journal
Endocrinology and metabolism clinics of North America
ISSN: 1558-4410
Titre abrégé: Endocrinol Metab Clin North Am
Pays: United States
ID NLM: 8800104
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
entrez:
23
5
2021
pubmed:
24
5
2021
medline:
1
4
2022
Statut:
ppublish
Résumé
Significant development has occurred in the treatment of postmenopausal osteoporosis. We review the most recent guidelines from the American Association of Clinical Endocrinologists/American College of Endocrinology, Endocrine Society, and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis/International Osteoporosis Foundation Guidelines.
Identifiants
pubmed: 34023036
pii: S0889-8529(21)00021-9
doi: 10.1016/j.ecl.2021.03.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
167-178Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The author has nothing to disclose. Principal Investigator – Romosozumab ARCH Trial.